1239600-18-0
1239600-18-0
Chemical Structure
LMT-28
- CAS No.: 1239600-18-0
- Formula:C17H29NO4
- Molecular Weight:311.42
IUPAC Name: (S)-3-((2S,3S)-3-hydroxy-2-methyl-4-methylenenonanoyl)-4-isopropyloxazolidin-2-one
InChIKey: UDXWSYOXIRPYFK-RRFJBIMHSA-N
SMILES: O=C1OC[C@H](C(C)C)N1C([C@@H](C)[C@H](O)C(CCCCC)=C)=O
Biological Activity: LMT-28 is an orally active and the first synthetic IL-6 inhibitor that functions through direct binding to gp130. LMT-28 shows low toxicity and selectively inhibits IL-6-induced phosphorylation of STAT3, JAK2, and gp130[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
LMT-28 | 99.29% | LMT-28 is an orally active and the first synthetic IL-6 inhibitor that functions through direct binding to gp130. LMT-28 shows low toxicity and selectively inhibits IL-6-induced phosphorylation of STAT3, JAK2, and gp130. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
LMT-28 (Standard) | ≥98% | LMT-28 (Standard) is the analytical standard of LMT-28 (HY-102084). This product is intended for research and analytical applications. LMT-28 is an orally active and the first synthetic IL-6 inhibitor that functions through direct binding to gp130. LMT-28 shows low toxicity and selectively inhibits IL-6-induced phosphorylation of STAT3, JAK2, and gp130. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
